Phase I Study of Immunotherapy of Metastatic Renal Cell Carcinoma by Direct Gene Transfer into Metastatic Lesions. University of Chicago, Chicago, Illinois
- 1 November 1994
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 5 (11) , 1357-1370
- https://doi.org/10.1089/hum.1994.5.11-1357
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Immunotherapy of malignancy by in vivo gene transfer into tumors.Proceedings of the National Academy of Sciences, 1993
- Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis.Proceedings of the National Academy of Sciences, 1992
- Site-Specific Gene Expression in Vivo by Direct Gene Transfer into the Arterial WallScience, 1990
- Immunotherapy of cancer using interleukin 2: current status and future prospectsImmunology Today, 1988
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Role of interleukin 2, interleukin 4, and alpha, beta, and gamma interferon in stimulating macrophage antibody-dependent tumoricidal activity.The Journal of Experimental Medicine, 1988
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Tumor Necrosis Factor (TNF)Science, 1985
- Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.The Journal of Experimental Medicine, 1985
- Natural killer cells: Artifact to reality:Cancer and Metastasis Reviews, 1983